Share on LinkedInShare on LinkedIn

ARTICLE · 14 APRIL 2020

The Drugs (Pricing Policy) Don't Work, They Just Make It Worse

A recent report published by the White House Council of Economic Advisers ("CEA") on drug pricing in the United States of America has put the cost of medicine and the access thereto by the poor.

South AfricaIntellectual Property

A recent report published by the White House Council of Economic Advisers ("CEA") on drug pricing in the United States of America has put the cost of medicine and the access thereto by the poor, firmly back in the spotlight, and on a global scale.

In the CEA report, President Donald Trump's administration argues that the USA pays higher prices for pharmaceuticals because other developed countries have systems in place to actively force down drug pricing. Some countries even force negative pricing on pharmaceutical manufacturers meaning that certain drug prices are adjusted downward each year, irrespective of increased input costs.

The argument from the CEA, as we understand it, goes like this: pharmaceutical companies charge high prices and achieve high margins on sales to support the massively expensive research and development activities to discover new drugs. The US, which has no real form of universal healthcare, basically relies on free market principles to

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from